September 8, 2017: ACTTION Submits Letter of Intent to FDA for Accelerometry
ACTTION has been assigned a Drug Development Tool number by FDA and submitted a Letter of Intent to begin development of the "Physical Activity Accelerometry Assessment for Analgesic Clinical Trials" (PAACT) and then apply for its qualification as a Clinical Outcome Assessment. ACTTION looks forward to the FDA's response and to developing an evidence-based and state-of-the-art approach for the assessment of physical activity using accelerometry.
News
ACTTION Guide to Clinical Trials of Pain Treatments
The ACTTION Guide to Clinical Trials of Pain Treatments consists of two supplements published in the journal Pain Reports that include a series of articles describing research designs and methods, study conduct, outcome measures, data analyses and interpretation, and reporting recommendations for clinical trials of acute and chronic pain treatments.
Part I includes 9 articles that can be found here, and Part II includes 6 articles that can be found here.